BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22779103)

  • 1. Exclusive plaque psoriasis of the lips: efficacy of combination therapy of topical tacrolimus, calcipotriol, and betamethasone dipropionate.
    Sehgal VN; Sehgal S; Verma P; Singh N; Rasool F
    Skinmed; 2012; 10(3):183-4. PubMed ID: 22779103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcirculatory modifications of psoriatic lesions during topical therapy.
    Rosina P; Giovannini A; Gisondi P; Girolomoni G
    Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A; Ponce-Olivera RM
    Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In touch with psoriasis: topical treatments and current guidelines.
    Murphy G; Reich K
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
    Calzavara-Pinton P; Rossi MT; Sala R; Venturini M
    G Ital Dermatol Venereol; 2011 Aug; 146(4):295-9. PubMed ID: 21785396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of generalized pustular psoriasis treated with topical tacrolimus.
    Nagao K; Ishiko A; Yokoyama T; Tanikawa A; Amagai M
    Arch Dermatol; 2003 Sep; 139(9):1219. PubMed ID: 12975175
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW; Houwing R; Sindrup JH; Wigchert S
    Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
    Henry F; Flagothier C; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2006 Mar; 61(3):139-41. PubMed ID: 16680996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
    Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
    J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.